Cargando…
Emerging vaccine manufacturers are innovating for the next decade
The Developing Countries Vaccine Manufacturers Network (DCVMN) is a public health-driven alliance consisting of 43 vaccine manufacturers from 14 countries and territories, operating under the mandate to protect all people against known and emerging infectious diseases, by improving the availability...
Autores principales: | Hayman, Benoit, Pagliusi, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242873/ https://www.ncbi.nlm.nih.gov/pubmed/32462140 http://dx.doi.org/10.1016/j.jvacx.2020.100066 |
Ejemplares similares
-
Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives
por: Jarrett, Stephen, et al.
Publicado: (2020) -
Strengthening clinical development activities and preparedness for vaccine manufacturers from emerging countries: Results of a survey
por: Viviani, Simonetta, et al.
Publicado: (2022) -
Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities
por: Hayman, Benoit, et al.
Publicado: (2021) -
Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
por: Pagliusi, Sonia, et al.
Publicado: (2023) -
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers
por: Dellepiane, Nora, et al.
Publicado: (2020)